Actively Recruiting
Effect of Vitamin C on Length of Hospital Stay in Children With Severe Pneumonia
Led by Children's Hospital and Institute of Child Health, Multan · Updated on 2026-02-17
90
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Severe pneumonia is a common and serious illness in young children and often requires hospital admission. This clinical trial aims to find out whether adding vitamin C to standard treatment can reduce the length of hospital stay in children under five years of age admitted with severe pneumonia. The main question this study seeks to answer is: Does giving vitamin C along with routine treatment help children with severe pneumonia recover faster and go home earlier compared to standard treatment alone? In this study, 90 children aged 2 to 59 months who are admitted to the Children's Hospital Multan with severe pneumonia will take part. Severe pneumonia is defined by fast breathing, fever, cough, and one or more danger signs such as difficulty feeding, repeated vomiting, seizures, bluish discoloration of lips, or noisy breathing. Children with chronic lung disease or weakened immunity will not be included. After parental consent, children will be randomly divided into two groups. One group will receive standard treatment only, which includes oxygen therapy and intravenous antibiotics according to hospital protocol. The second group will receive the same standard treatment plus a daily dose of vitamin C. Neither group will receive any experimental or unapproved therapy. Researchers will closely monitor each child's recovery, including improvement in breathing rate, temperature, oxygen levels, and overall clinical condition. The child will be discharged when the treating physician determines that recovery criteria are met. The number of days spent in the hospital from the start of treatment until discharge will be recorded. By comparing the average hospital stay between the two groups, this study aims to determine whether vitamin C is a useful and safe add-on treatment for severe pneumonia in young children. The findings may help improve care and reduce hospital stay for children with severe pneumonia in the future.
CONDITIONS
Official Title
Effect of Vitamin C on Length of Hospital Stay in Children With Severe Pneumonia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Presenting with severe pneumonia
- Pneumonia duration of 48 hours or less
- Age between 2 months and 59 months (under 5 years)
You will not qualify if you...
- Congenital heart disease
- Chronic respiratory illnesses such as asthma, post tuberculosis bronchiectasis, and cystic fibrosis
- Immunosuppressed conditions including primary immune deficiency, malignancy, or steroid therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Children Hospital and Institute of Child Health
Multan Khurd, Punjab Province, Pakistan, 60000
Actively Recruiting
Research Team
M
Muhammad S Principal Investigator, MBBS
CONTACT
A
Ayesha F Assistant Professor, FCPS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here